Screener
Praxis Precision Medicines, Inc. PRAX Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 9:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001689548-26-000047
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Payments of tax withholdings related to vesting of restricted stock units | (12,923) | (1,195) |
| Proceeds from exercise of stock options | 1,119 | 560 |
| Net cash provided by financing activities | 609,431 | 54,269 |
| Increase (decrease) in cash, cash equivalents and restricted cash | 179,004 | (49,805) |
| Cash, cash equivalents and restricted cash, beginning of period | 357,745 | 215,788 |
| Cash, cash equivalents and restricted cash, end of period | $536,749 | $165,983 |
| Reconciliation of cash, cash equivalents and restricted cash: | ||
| Cash and cash equivalents | 536,333 | 165,567 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Praxis Precision Medicines, Inc.'s net change in cash?
- Praxis Precision Medicines, Inc. (PRAX) reported net change in cash of $179M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s net change in cash changed year-over-year?
- Praxis Precision Medicines, Inc.'s net change in cash increased by 459.4% year-over-year, from -$49.81M to $179M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s net change in cash?
- Over 2 years (2022 to 2025), Praxis Precision Medicines, Inc.'s net change in cash has grown at a 29.9% compound annual growth rate (CAGR), from -$84.09M to $141.96M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Praxis Precision Medicines, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude